Skip to main navigation Skip to search Skip to main content

Reactivity and amplification efficiency of the NASBA HIV-1 RNA amplification system with regard to different HIV-1 subtypes

  • E Gobbers
  • , K Fransen
  • , T Oosterlaken
  • , W Janssens
  • , L Heyndrickx
  • , T Ivens
  • , K Vereecken
  • , R Schoones
  • , P van de Wiel
  • , G van der Groen

Research output: Contribution to journalA1: Peer-reviewed journal articlespeer-review

Abstract

In view of the genetic diversity of the human immunodeficiency viras Type 1, we assessed the sensitivity and quantification efficiency of the HIV-1 RNA NASBA amplification system with respect to different HIV-1 subtypes and recombinants. Twenty cell culture supernatants representing 17 HIV-1 group M and 3 group O strains were tested, and NASBA RNA loads were compared with results obtained with a RT-PCR based HIV-1 RNA quantitation method, with p24-antigen concentrations and with the infective dose. The current HIV-1 RNA NASBA seemed suitable to quantitate representatives of different HIV-1 M subtypes. Differences between NASBA and RT-PCR loads were observed for certain HIV-1 M strains. Significantly lower RT-PCR loads were measured for most gag A, gag B and gag F strains, whereas NASBA detected lower copy numbers in 1 gag H strain and 1 gag H/env G recombinant. NASBA was not able to quantify 1 HIV-1 group M recombinant. Some of these differences could be explained by the presence and position of mismatches with primers. HIV-1 group O strains were not detectable by both RNA amplification methods. A firm correlation was not observed between the measured RNA loads and either the p24-antigen concentration or the infective dose.
Original languageEnglish
JournalJournal of Virological Methods
Volume66
Issue number2
Pages (from-to)293-301
ISSN0166-0934
DOIs
Publication statusPublished - 1997

Keywords

  • B780-tropical-medicine
  • Virology
  • HIV-1
  • Amplification
  • Reactivity
  • NASBA
  • RNA
  • Subtypes

Fingerprint

Dive into the research topics of 'Reactivity and amplification efficiency of the NASBA HIV-1 RNA amplification system with regard to different HIV-1 subtypes'. Together they form a unique fingerprint.

Cite this